Derivation of the sledai. A disease activity index for lupus patients
Claire Bombardier, Dafna D. Gladman, Murray B. Urowitz, Dominique Caron, Chi Hsing Chang, D A Bloch, Paul Corey, John L. Decker, John M. Esdaile, James F. Fries, Ellen M. Ginzler, Charles H. Goldsmith, Marc C. Hochberg, John Verrier Jones, Nicole G. H. LeRICHE, Matthew H. Liang, Michael D. Lockshin, Larry R. Muenz, David L. Sackett, Peter H. Schur
Arthritis & Rheumatism · 1992 · 4,574 citations
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P., Decker, J. L., Esdaile, J. M., Fries, J. F., Ginzler, E. M., Goldsmith, C. H., Hochberg, M. C., Jones, J. V., LeRICHE, N. G. H., Liang, M. H., Lockshin, M. D., … Schur, P. H. (1992). Derivation of the sledai. A disease activity index for lupus patients. Arthritis & Rheumatism, 35(6), 630–640. https://doi.org/10.1002/art.1780350606
In text: (Bombardier et al., 1992)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
OBJECTIVE: To standardize outcome measures in systemic lupus erythematosus (SLE). Three indices were identified which could adequately describe outcome (disease activity, damage from disease, and health status); we describe here the development of the Disease Activity Index. METHODS: Twenty-four variables were identified as important factors in a disease activity index. These were used to generate 574 patient profiles, which were rated on a disease activity scale of 0-10 by 14 rheumatologists. A second rating of 10 of the profiles yielded scores that were not significantly different from the first, indicating that experienced clinicians can reliably make global estimates of disease activity. Multiple regression models were used to estimate the relative importance of the 24 clinical variables in the physicians' global rating of disease activity. These were estimated on a "training set" of 75% of physicians' ratings, and then validated on a "testing set," consisting of the remaining 25% of physicians' ratings. RESULTS: The explanatory power of the models in the training set was high (R2 = 0.93). The models' regression coefficients for the organ systems were simplified for easier use in clinical practice. This generated a "weighted" index of 9 organ systems for disease activity in SLE, the SLEDAI, as follows: 8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal, immunologic, and 1 for constitutional and hematologic. The maximum theoretical score is 105, but in practice, few patients have scores greater than 45. The SLEDAI predicted well the physicians' ratings in the testing set (Pearson's correlation coefficients = 0.64-0.79). CONCLUSION: The SLEDAI is a validated model of experienced clinicians' global assessments of disease activity in lupus. It represents the consensus of a group of experts in the field of lupus research.
Related papers
- The 1982 revised criteria for the classification of systemic lupus erythematosus1982
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative2010
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides2012
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus2012
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy1998
Metadata from OpenAlex (CC0). Citations are generated from the published record.